Le Lézard
Classified in: Health, Science and technology

PCM Releases an Exclusive Market Check Tool to Streamline RFP Process for Brokers


Prescription Care Management (PCM) has launched the newest version of its automated RFP tool that provides benefits brokers with an efficient, cost-effective way to dynamically reprice claims for unprecedented contract visibility.

RENO, Nev., May 24, 2022 /PRNewswire-PRWeb/ -- PCM's exclusive Market Check fills a market need for a more economical way to streamline complex RFP, RFI, RFQ, and market checks. Built into PCM's interactive pharmacy platform, Market Check allows benefits brokers to evaluate multiple contract plan designs and pricing structures with the click of a button.

Brokers begin by securely transmitting a claims file. Then, utilizing PCM's web-based interactive platform, they dynamically edit contract details, including plan pay, copay, admin fees, rebates, and employee cost share for multiple pre-loaded contracts. For a more custom approach, brokers can build out custom contract details using a fillable template.

Evaluating how the selected contracts and pricing structures affect copay and claims provides brokers with data to negotiate better contract terms and rates for their clients. By eliminating the resource strain caused by procuring proposals, Market Check gives brokers more time and money to focus on meeting specific client needs.

Garret D'Antoni, CFO at PCM, provides insight into the motive behind the new tool, "PCM built a dynamic RFP tool that adjusts and adapts to any contract the client might want. When also considering utilization, Market Check gives brokers the opportunity to match their clients to the best PBM contract available."

Ahead of this year's RFP season, brokers can schedule a complimentary Market Check at https://www.pcmsavings.com/market-check

Paired with PCM's performance evaluation tool, Market Check provides brokers with a scalable strategy to streamline RFPs and validate contract decisions.

Media Contact

Erin Heuett, Prescription Care Management, 1 775-234-5510, [email protected]

 

SOURCE Prescription Care Management


These press releases may also interest you

at 16:54
Hondros College of Nursing Announces Launch of Medical Assisting Program
Hondros College of Nursing (HCN) will introduce a new Medical Assisting program at its six Ohio campuses in 2024 to meet the growing need for medical assistants in a variety of settings.  According to the U.S. Bureau of Labor Statistics (BLS),...

at 16:45
Mahesh Krishnan Elected to Halozyme's Board of Directors
Halozyme Therapeutics, Inc. ("Halozyme") today announced the election of Mahesh Krishnan, M.D. to its Board of Directors. Dr. Krishnan has more than 20 years of experience in healthcare, biotechnology and health services. "Mahesh is a dynamic and...

at 16:35
Geron to Announce First Quarter 2024 Financial Results on May 2, 2024
Geron Corporation , a late-stage clinical biopharmaceutical company, today announced that it will release its first quarter 2024 financial results and business highlights before the market opens on Thursday, May 2, 2024 via press release, which will...

at 16:35
Tilray Brands Celebrates Big Wins at the Craft Brewer's Conference and 2024 World Beer Cup, the Most Prestigious Beer Competition in the World
Tilray Brands, Inc. , a leader in the craft beer and cannabis-lifestyle industries, celebrates high honors and awards at the 2024 Craft Brewer's Conference and World Beer Cup. 10 Barrel Brewing won four craft beer awards and 10...

at 16:34
Fusion Pharmaceuticals Mails Circular for Special Meeting of Shareholders and Announces Receipt of Interim Order
Fusion Pharmaceuticals Inc. , a clinical-stage oncology company focused on developing next-generation radioconjucates (RCs) as precision medicines, today announced that it has filed and is in the process of mailing the management information circular...

at 16:30
Evernorth announces Humira biosimilar available at $0 out of pocket for Accredo patients in June
In an important step toward driving long-term affordability and access to treatments for chronic and complex conditions, Evernorth Health Services announced that it will have a Humira® biosimilar available for $0 out of pocket for eligible...

More news about Health...


News published on and distributed by: